News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
722,055 Results
Type
Article (41210)
Company Profile (267)
Press Release (680568)
Multimedia
Podcasts (80)
Webinars (17)
Section
Business (204831)
Career Advice (2023)
Deals (35556)
Drug Delivery (110)
Drug Development (81578)
Employer Resources (173)
FDA (16423)
Job Trends (14946)
News (346777)
Policy (32763)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2572)
Accelerated approval (32)
Adcomms (25)
Allergies (137)
Alliances (49670)
ALS (167)
Alzheimer's disease (1658)
Antibody-drug conjugate (ADC) (308)
Approvals (16684)
Artificial intelligence (500)
Autoimmune disease (143)
Automation (37)
Bankruptcy (361)
Best Places to Work (11638)
BIOSECURE Act (20)
Biosimilars (187)
Biotechnology (174)
Bladder cancer (159)
Brain cancer (56)
Breast cancer (633)
Cancer (4773)
Cardiovascular disease (395)
Career advice (1708)
Career pathing (35)
CAR-T (276)
CDC (44)
Celiac Disease (2)
Cell therapy (730)
Cervical cancer (37)
Clinical research (69619)
Collaboration (1669)
Company closure (4)
Compensation (1138)
Complete response letters (55)
COVID-19 (2707)
CRISPR (87)
C-suite (810)
Cystic fibrosis (143)
Data (6147)
Decentralized trials (2)
Denatured (25)
Depression (130)
Diabetes (495)
Diagnostics (6671)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (241)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (225)
Earnings (90062)
Editorial (55)
Employer branding (21)
Employer resources (151)
Events (117268)
Executive appointments (958)
FDA (19498)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1445)
Gene editing (191)
Generative AI (42)
Gene therapy (581)
GLP-1 (962)
Government (4655)
Grass and pollen (6)
Guidances (383)
Healthcare (18890)
HIV (55)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (244)
Immuno-oncology (53)
Indications (103)
Infectious disease (2965)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (242)
Interviews (315)
IPO (16649)
IRA (49)
Job creations (3644)
Job search strategy (1428)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (546)
Leadership (30)
Legal (7953)
Liver cancer (91)
Longevity (14)
Lung cancer (646)
Lymphoma (371)
Machine learning (42)
Management (59)
Manufacturing (778)
MASH (161)
Medical device (13753)
Medtech (13805)
Mergers & acquisitions (19965)
Metabolic disorders (1250)
Multiple sclerosis (155)
NASH (16)
Neurodegenerative disease (307)
Neuropsychiatric disorders (86)
Neuroscience (2864)
Neurotech (1)
NextGen: Class of 2026 (6521)
Non-profit (4508)
Now hiring (65)
Obesity (586)
Opinion (256)
Ovarian cancer (164)
Pain (195)
Pancreatic cancer (223)
Parkinson's disease (279)
Partnered (33)
Patents (486)
Patient recruitment (469)
Peanut (55)
People (58841)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21735)
Phase 2 (30633)
Phase 3 (22812)
Pipeline (5073)
Policy (278)
Postmarket research (2572)
Preclinical (9244)
Press Release (64)
Prostate cancer (234)
Psychedelics (47)
Radiopharmaceuticals (278)
Rare diseases (813)
Real estate (5960)
Recruiting (69)
Regulatory (24452)
Reports (51)
Research institute (2389)
Resumes & cover letters (351)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (146)
Series A (237)
Series B (184)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3621)
State (2)
Stomach cancer (18)
Supply chain (104)
Tariffs (84)
The Weekly (53)
Vaccines (983)
Venture capital (86)
Weight loss (376)
Women's health (87)
Worklife (18)
Date
Today (5)
Last 7 days (592)
Last 30 days (2189)
Last 365 days (29799)
2026 (2813)
2025 (30189)
2024 (35242)
2023 (40098)
2022 (51217)
2021 (55765)
2020 (54123)
2019 (46580)
2018 (35042)
2017 (32146)
2016 (31510)
2015 (37588)
2014 (31361)
2013 (26389)
2012 (28624)
2011 (29312)
2010 (27386)
Location
Africa (737)
Alabama (83)
Alaska (7)
Arizona (305)
Arkansas (13)
Asia (39365)
Australia (6463)
California (11155)
Canada (3249)
China (1083)
Colorado (471)
Connecticut (469)
Delaware (332)
Europe (84722)
Florida (1661)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (850)
India (62)
Indiana (513)
Iowa (22)
Japan (417)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1369)
Massachusetts (7985)
Michigan (319)
Minnesota (621)
Mississippi (5)
Missouri (125)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2966)
New Mexico (28)
New York (2943)
North Carolina (1433)
North Dakota (8)
Northern California (5435)
Ohio (330)
Oklahoma (21)
Oregon (41)
Pennsylvania (2254)
Puerto Rico (22)
Rhode Island (47)
South America (1108)
South Carolina (65)
South Dakota (1)
Southern California (4340)
Tennessee (172)
Texas (1718)
United States (39539)
Utah (333)
Vermont (1)
Virginia (256)
Washington D.C. (81)
Washington State (913)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
722,055 Results for "anticancer inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PharmaResearch Receives U.S. FDA Clearance to Initiate Phase 1 Clinical Trial of Nano Anticancer Drug, PRD-101
February 6, 2026
·
2 min read
Press Releases
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025
November 10, 2025
·
5 min read
Press Releases
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug ‘SNB-101' on Gastric Cancer.
December 24, 2025
·
3 min read
Press Releases
BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models
November 5, 2025
·
4 min read
Cancer
J&J’s Darzalex Faspro Notches Another Multiple Myeloma Indication, Pushing Into Frontline
Darzalex Faspro, in combination with an anti-cancer triplet, is the first anti-CD38-based regimen for newly diagnosed patients with multiple myeloma, regardless of eligibility for stem cell transplantation.
January 28, 2026
·
2 min read
·
Tristan Manalac
Antibody-drug conjugate (ADC)
Daiichi Sankyo Dumps Next-Gen ADC From Development Pipeline
DS-9606 was supposed to be the first antibody-drug conjugate in Daiichi Sankyo’s line of anti-cancer assets to use a modified pyrrolobenzodiazepine payload.
February 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals
January 29, 2026
·
2 min read
Press Releases
MAIA Biotechnology Announces Publication of Interim Clinical Data on Telomere Targeting Anticancer Agent in Peer-Reviewed Journal Cells
August 28, 2025
·
5 min read
Biotech Beach
AntiCancer Inc. Has Received a New Patent That Revolutionizes Individualized Mouse Models of Human Cancer Patients by Increasing the Patient-tumor Establishment Rate in Mice to Close to 100%
AntiCancer Inc. announced it has just received US Patent 11,871,731 that describes a method to increase the rate of establishment of patient tumors in mice to close to 100%.
January 29, 2024
·
1 min read
Press Releases
Florida Cancer Specialists & Research Institute Physician Leaders Examine Best Practices To Improve Speed, Efficiency & Reduce Cost In Bringing Anti-cancer Medicines to Patients
October 3, 2025
·
3 min read
1 of 72,206
Next
